Toxicity of neoadjuvant and definitive chemoradiotherapy for esophageal cancer in patients with hepatic impairment: a retrospective cohort study
dc.rights.license | CC-BY-NC-ND | |
dc.contributor.advisor | Egberts, A.C.G. | |
dc.contributor.author | Stammers, Julian | |
dc.date.accessioned | 2023-09-20T23:00:45Z | |
dc.date.available | 2023-09-20T23:00:45Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/45194 | |
dc.description.sponsorship | Utrecht University | |
dc.language.iso | EN | |
dc.subject | Onderzoek naar de bijwerkingen van paclitaxel en carboplatine bij patiënten met leverfunctiestoornissen. Specifiek in patiënten met slokdarmkanker die worden behandeld met het protocol uit de CROSS-study. | |
dc.title | Toxicity of neoadjuvant and definitive chemoradiotherapy for esophageal cancer in patients with hepatic impairment: a retrospective cohort study | |
dc.type.content | Master Thesis | |
dc.rights.accessrights | Open Access | |
dc.subject.courseuu | Pharmacy | |
dc.thesis.id | 11592 |